症状性子宫内膜异位症阶梯式管理:一项参与式研究倡议
前瞻性单臂自身对照研究纳入157例连续就诊的症状性子宫内膜异位症患者,在充分信息告知与共享决策后启动包含口服避孕药、炔诺酮醋酸酯2.5 mg/d、地诺孕素2 mg/d及手术四步的阶梯式方案。意向性分析中总体满意度为62%(95/152,95%CI 55%-70%),所有疼痛评分及SF-12躯体与心理成分评分均显著改善,FSFI评分无明显变化。
要点
- 12个月时106例仍用口服避孕药,23例用炔诺酮醋酸酯,3例用地诺孕素,4例接受手术。
- 意向性分析总体满意度62%(95/152,95%CI 55%-70%),排除5例因妊娠意愿退出者。
- 12个月随访所有疼痛评分及SF-12躯体、心理成分评分显著改善,FSFI评分无明显变化。
核心结论
- 多数选择阶梯式方案的子宫内膜异位症相关盆腔痛女性对口服避孕药和低成本孕激素治疗表示满意,升级至昂贵孕激素或手术的需求有限。
研究设计与样本
- 前瞻性、单臂、自身对照研究,在学术科室开展,纳入157例连续转诊或自行就诊的症状性子宫内膜异位症患者。
- 干预为系统详细的药物与手术治疗信息告知,随后共享决策启动含三个序贯药物治疗步骤(口服避孕药;炔诺酮醋酸酯2.5 mg/d;地诺孕素2 mg/d)及第四步手术的阶梯式方案,药物无效或不耐受时升级。
主要发现
- 12个月研究期末106例仍使用口服避孕药,23例使用炔诺酮醋酸酯,3例使用地诺孕素,4例已接受手术,21例(13%)退出研究。
- 意向性分析排除5例因妊娠意愿退出者后,阶梯式方案总体满意度为62%(95/152,95%CI 55%-70%)。
- 12个月随访时所有疼痛症状评分及SF-12躯体与心理成分汇总评分均显著改善,FSFI评分无明显变化。
关键数值与推荐
- 满意度采用五分类量表评估:非常满意、满意、既不满意也不不满意、不满意、非常不满意。
- 疼痛症状采用0-10分数值评定量表(NRS)评估,生活质量采用Short Form 12问卷(SF-12)评估,性功能采用女性性功能指数(FSFI)评估。
- 阶梯式方案药物治疗步骤为口服避孕药、炔诺酮醋酸酯2.5 mg/d、地诺孕素2 mg/d,第四步为手术,药物无效或不耐受时升级。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the proportion of patients with symptomatic endometriosis satisfied with their medical treatment 12 months after enrollment in a stepped-care management protocol. DESIGN: Prospective, single-arm, self-controlled study. SETTING: Academic department. PATIENT(S): A cohort of 157 consecutive patients referred or self-referred to our center for symptomatic endometriosis. INTERVENTIONS(S): Systematic detailed information process on medical and surgical treatment followed by a shared decision to start a stepped-care protocol including three subsequent medical therapy steps (oral contraception [OC]; 2.5 mg/d norethindrone acetate [NETA]; 2 mg/d dienogest [DNG]) and a fourth surgical step. Stepping up was triggered by drug inefficacy/intolerance. MAIN OUTCOME MEASURE(S): Satisfaction with treatment was assessed according to a five-category scale (very satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied, very dissatisfied). Variations were measured in pain symptoms with the use of a 0-10-point numeric rating scale (NRS), in quality of life with the use of the Short Form 12 questionnaire (SF-12), and in sexual functioning with the use of the Female Sexual Function Index (FSFI). RESULT(S): At the end of the 12-month study period, 106 women were still using OC, 23 were using NETA, three were using DNG, and four had undergone surgery. Twenty-one participants (13%) dropped out from the study. In intention-to-treat analysis, excluding five drop-outs for pregnancy desire, the overall satisfaction rate with the stepped-care protocol was 62% (95/152; 95% CI 55%-70%). By 12-month follow-up, significant improvements were observed in all pain symptom scores and in SF-12 physical and mental component summary scores, whereas FSFI scores did not vary substantially. CONCLUSION(S): Most women with endometriosis-associated pelvic pain who chose a stepped-care approach were satisfied with OC and a low-cost progestin for the treatment of their symptoms. The need to step up to an expensive progestin or surgery was marginal.
引用
- Vercellini P, Donati A, Ottolini F, et al. A stepped-care approach to symptomatic endometriosis management: a participatory research initiative. Fertil Steril. 2018. PMID: 29871796. doi:10.1016/j.fertnstert.2018.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。